Qingdao NovelBeam Technology Co.,Ltd. (SHA:688677)
40.60
-0.76 (-1.84%)
Jun 13, 2025, 2:45 PM CST
SHA:688677 Revenue
Qingdao NovelBeam Technology had revenue of 146.89M CNY in the quarter ending March 31, 2025, with 24.86% growth. This brings the company's revenue in the last twelve months to 472.08M, up 7.34% year-over-year. In the year 2024, Qingdao NovelBeam Technology had annual revenue of 442.83M, down -5.90%.
Revenue (ttm)
472.08M
Revenue Growth
+7.34%
P/S Ratio
10.25
Revenue / Employee
561.33K
Employees
841
Market Cap
4.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 442.83M | -27.77M | -5.90% |
Dec 31, 2023 | 470.60M | -6.22M | -1.31% |
Dec 31, 2022 | 476.82M | 167.15M | 53.97% |
Dec 31, 2021 | 309.67M | 34.48M | 12.53% |
Dec 31, 2020 | 275.20M | 22.33M | 8.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |